Sacral Neuromodulation in Pregnant Women-A Case Report and Literature Review.
Int J Environ Res Public Health
; 19(14)2022 07 08.
Article
en En
| MEDLINE
| ID: mdl-35886191
ABSTRACT
Millions of women around the world suffer from an overactive bladder and urinary retention. A significant number of them are of reproductive age. For 25 years, SNM has been an effective therapy for treatment-resistant hyperactive bladder and idiopathic urinary retention. The paper presents a case of a 35-year-old pregnant woman with an overactive bladder resistant to pharmacological treatment, who responded positively to sacral neuromodulation. The patient decided against deactivating the neuromodulator and, after an uneventful course of pregnancy, she gave birth by a caesarean section to a healthy female infant. The use of SNM in pregnant patients remains a constant clinical challenge. The current literature was reviewed, but published studies do not provide a clear answer. Further studies with a long follow-up period are necessary to determine more accurately the effects of SNM therapy on the fetus and the course of pregnancy. Currently, it is recommended to deactivate SNM during pregnancy. However, it seems that an individual approach to the patient with information on the risks and benefits of continuing or discontinuing therapy should be the current procedure.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Terapia por Estimulación Eléctrica
/
Retención Urinaria
/
Vejiga Urinaria Hiperactiva
Límite:
Adult
/
Female
/
Humans
/
Pregnancy
Idioma:
En
Año:
2022
Tipo del documento:
Article